Shandong Boyuan Pharmaceutical&Chemical
301617
FORSTAR
835640
Cre8 Direct(Ningbo)Co.,Ltd.
300703
Minami Acoustics
301383
ASR Microelectronics
688220
(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Money funds | 286.47%6.05M | 148.90%7.88M | 474.74%3.48M | -73.63%4.44M | -90.40%1.56M | -78.68%3.17M | -97.15%605.45K | -27.54%16.84M | -0.04%16.29M | -67.37%14.85M |
Transactional financial assets | --107.45K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Notes receivable and accounts receivable | -9.99%96.79M | -10.11%86.58M | -1.67%83.89M | 19.34%115.44M | 6.09%107.53M | -13.05%96.32M | -8.16%85.31M | -23.25%96.73M | -21.08%101.36M | 2.84%110.77M |
-Notes receivable | -21.41%1.37M | --0 | -75.66%205.8K | 22.62%1.4M | 50.78%1.75M | 302.15%1.72M | 11.23%845.5K | -57.02%1.14M | 36.98%1.16M | -80.96%427.5K |
-Accounts receivable | -9.80%95.42M | -8.48%86.58M | -0.93%83.68M | 19.30%114.04M | 5.58%105.79M | -14.27%94.6M | -8.32%84.47M | -22.52%95.59M | -21.46%100.2M | 4.63%110.35M |
Other receivables (including interest and dividends) | 117.49%542.42K | -75.76%472.5K | -78.89%596.56K | -9.63%3.86M | -97.27%249.4K | -62.67%1.95M | 26.86%2.83M | -61.21%4.27M | 2,601.57%9.12M | 1,313.67%5.22M |
-Other receivable | ---- | -75.76%472.5K | ---- | ---- | ---- | -62.67%1.95M | ---- | -61.21%4.27M | ---- | 1,313.67%5.22M |
Advance payment | -64.76%6.72M | -33.40%9.97M | -31.74%7.75M | -69.00%1.36M | 11.38%19.07M | 33.76%14.97M | -19.12%11.35M | 375.25%4.39M | 72.78%17.12M | -3.61%11.19M |
Inventories | -22.69%27.98M | 13.92%35.21M | 15.73%35.93M | -17.23%19.96M | 7.79%36.19M | -12.13%30.91M | 14.17%31.05M | 22.66%24.12M | 13.55%33.58M | 59.88%35.18M |
Receivable financing | -10.19%31.14M | 152.48%32.8M | 55.07%35.65M | 88.03%36.3M | 79.18%34.68M | 139.72%12.99M | -4.29%22.99M | -40.99%19.3M | 19.37%19.35M | -60.86%5.42M |
Other current assets | --1.44M | 1,462.32%661.13K | 2,040.88%803.27K | -11.17%413.69K | ---- | --42.32K | --37.52K | --465.72K | ---- | ---- |
Total current assets | -14.31%170.76M | 8.25%173.58M | 9.03%168.1M | 9.42%181.77M | 1.25%199.28M | -12.20%160.35M | -15.10%154.17M | -22.22%166.12M | -1.96%196.82M | -9.16%182.64M |
Non Current assets | ||||||||||
Investment real estate | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -7.15%1.87M | -7.02%1.91M |
Fixed assets | ---- | 0.24%128.46M | ---- | ---- | ---- | -16.78%128.16M | ---- | -16.17%135.09M | ---- | -13.94%153.99M |
Constru in process | ---- | -92.79%666.07K | ---- | ---- | ---- | 116.60%9.23M | ---- | 31.25%5.55M | ---- | 157.47%4.26M |
Intangible assets | -2.44%23.58M | -2.43%23.72M | -2.46%23.87M | -2.50%24.02M | -18.67%24.17M | -18.73%24.31M | -18.75%24.47M | -18.75%24.64M | -2.66%29.71M | -2.64%29.92M |
Other non current assets | ---- | ---- | ---- | -90.88%225.88K | ---- | ---- | ---- | 1,918.79%2.48M | ---- | ---- |
Total non current assets | -6.21%148.72M | -5.48%152.85M | -4.10%156.06M | -4.94%159.47M | -14.71%158.57M | -14.93%161.71M | -15.88%162.73M | -15.19%167.75M | -11.39%185.91M | -10.92%190.08M |
Total assets | -10.72%319.48M | 1.36%326.43M | 2.29%324.16M | 2.21%341.24M | -6.50%357.85M | -13.59%322.06M | -15.50%316.9M | -18.84%333.87M | -6.78%382.73M | -10.06%372.72M |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Short term loan | 4.76%220M | 2.33%220M | -0.01%215M | 38.67%215.24M | 50.00%210M | 53.57%215M | 53.59%215.02M | 10.72%155.22M | -0.21%140M | -17.65%140M |
Transactional financial liabilities | ---- | ---- | ---- | --20.44K | ---- | ---- | ---- | ---- | ---- | ---- |
Notes payable and accounts payable | -41.81%18.65M | -9.71%18.4M | -28.43%17.09M | 43.70%27.95M | 1.45%32.05M | -9.98%20.38M | -9.84%23.88M | -38.40%19.45M | -6.30%31.59M | -22.36%22.64M |
-Notes payable | -56.70%3.07M | 169.81%3.92M | 667.27%6.63M | 693.40%10.16M | 857.90%7.08M | --1.45M | 67.11%863.88K | -86.97%1.28M | -94.38%739.25K | ---- |
-Accounts payable | -37.58%15.58M | -23.50%14.48M | -54.54%10.46M | -2.10%17.79M | -19.07%24.97M | -16.40%18.93M | -11.37%23.02M | -16.46%18.17M | 50.14%30.85M | -10.61%22.64M |
Contract liabilities | 20.78%178.25K | --162.49K | -50.61%32.97K | -38.45%47.72K | -53.61%147.58K | --0 | -44.91%66.74K | -23.12%77.53K | -63.66%318.13K | -50.99%461.74K |
Advance receipts | ---- | ---- | ---- | ---- | ---- | -99.63%85.51K | ---- | ---- | --29M | --23M |
Salaries payable | 30.93%2.18M | -1.06%2.19M | -0.54%2.32M | -18.68%3.06M | 0.99%1.67M | 107.57%2.21M | 56.90%2.33M | 2.89%3.77M | -42.64%1.65M | -60.55%1.06M |
Taxs payable | -53.27%908.82K | -52.82%627.43K | ---- | -75.79%1.26M | -53.25%1.94M | -59.75%1.33M | -90.07%482.1K | 23.83%5.21M | 266.05%4.16M | 95.81%3.3M |
Other payable (including interest and dividends) | -2.23%1.42M | -94.01%1.52M | -88.82%1.52M | -98.30%1.38M | -98.39%1.45M | -66.77%25.38M | -82.04%13.61M | -7.14%81.22M | 17.61%90.29M | 24.68%76.36M |
-Other payable | ---- | -94.01%1.52M | ---- | ---- | ---- | -66.77%25.38M | ---- | -7.14%81.22M | ---- | 24.68%76.36M |
Other current liabilities | ---- | ---- | ---- | -98.00%6.2K | ---- | --0 | ---- | 1,957.70%310.08K | ---- | ---- |
Total current liabilities | -1.59%243.34M | -8.13%242.9M | -7.61%235.96M | -6.14%248.97M | -16.75%247.26M | -0.92%264.39M | 2.69%255.39M | -0.74%265.25M | 16.17%297M | 0.41%266.83M |
Current liabilities | ||||||||||
Estimate liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -81.90%10.9M | -70.21%22.21M |
Total non current liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -81.90%10.9M | -70.21%22.21M |
Total liabilities | -1.59%243.34M | -8.13%242.9M | -7.61%235.96M | -6.14%248.97M | -19.70%247.26M | -8.53%264.39M | -12.23%255.39M | -19.21%265.25M | -2.53%307.9M | -15.06%289.05M |
Shareholders equity | ||||||||||
Paid-in capital | 0.00%126.67M | 0.00%126.67M | 0.00%126.67M | 0.00%126.67M | -1.61%126.67M | -1.61%126.67M | -1.61%126.67M | -1.61%126.67M | 0.00%128.75M | 1.64%128.75M |
Capital reserve funds | 0.00%188.92M | 0.00%188.92M | 0.00%188.92M | 0.00%188.92M | -0.57%188.92M | -0.57%188.92M | -0.57%188.92M | -0.57%188.92M | 0.83%190M | 5.47%190M |
Surplus reserve funds | -0.00%43.04M | 0.00%43.04M | 0.00%43.04M | 0.00%43.04M | 0.00%43.04M | 0.00%43.04M | 0.00%43.04M | 0.00%43.04M | 0.00%43.04M | 0.00%43.04M |
Retained profit | -13.89%-282.48M | 8.59%-275.09M | 8.98%-270.43M | 8.15%-266.36M | 10.32%-248.04M | -12.41%-300.95M | -11.14%-297.12M | -8.07%-290M | -4.16%-276.58M | 2.90%-267.74M |
Less:Treasury stock | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --10.38M | --10.38M |
Shareholders equity without minority interests | -31.15%76.14M | 44.84%83.53M | 43.38%88.2M | 34.46%92.27M | 47.79%110.59M | -31.07%57.68M | -26.84%61.51M | -17.38%68.62M | -20.97%74.83M | 12.88%83.67M |
Total shareholder equity | -31.15%76.14M | 44.84%83.53M | 43.38%88.2M | 34.46%92.27M | 47.79%110.59M | -31.07%57.68M | -26.84%61.51M | -17.38%68.62M | -20.97%74.83M | 12.88%83.67M |
Total liabilityies and equity | -10.72%319.48M | 1.36%326.43M | 2.29%324.16M | 2.21%341.24M | -6.50%357.85M | -13.59%322.06M | -15.50%316.9M | -18.84%333.87M | -6.78%382.73M | -10.06%372.72M |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Reservations with explanatory notes | -- | -- |
Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.